Results
1 -
10 of
37Catalytic Assays for Human Cytochrome P450, Cytochrome P450 Protocols Direct Chiral HPLC Method for the Simultaneous Determination of Warfarin Enantiomers and Its Impurities in Raw Material and Pharmaceutical Formulation: Application of Chemometric Protocol, Chromatographia Cases Journal.
Assessment of specific risks for the recurrence of deep vein thrombosis: a case report, Cases Journal Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes, European Journal of Clinical Pharmacology Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin, European Journal of Clinical Pharmacology A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A2A-Receptor Agonist, in Healthy Male Volunteers, Clinical Pharmacokinetics Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3, European Journal of Clinical Pharmacology Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man, European Journal of Clinical Pharmacology Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes, European Journal of Clinical Pharmacology Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults, Advances in Therapy